TIFA suppresses hepatocellular carcinoma progression via MALT1-dependent and -independent signaling pathways.
Shen W, Du R, Li J, Luo X, Zhao S, Chang A, Zhou W, Gao R, Luo D, Wang J, Hao N, Liu Y, Chen Y, Luo Y, Sun P, Yang S, Luo N, Xiang R.
Shen W, et al. Among authors: wang j.
Signal Transduct Target Ther. 2016 Jul 22;1:16013. doi: 10.1038/sigtrans.2016.13. eCollection 2016.
Signal Transduct Target Ther. 2016.
PMID: 29263897
Free PMC article.